News Chart BioCryst Pharmaceuticals, Inc.

Equities

BCRX

US09058V1035

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-13 EDT			5-day change	1st Jan Change
5.63 ^USD	+5.83%		+6.83%	-6.01%

05-13	BioCryst Says Orladeyo Granted Approval in Mexico	MT
05-09	BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO	CI

cbf7463cec87ba0853e.0n1QUpFRoSApog15QWQR_PHT8TKh7MTypOH6tvL5AqM.4zchK-ES401G82Q1eTVytcO6t3TApvKkk4WR3YfBb5rnRX0r0CHWRW2TZg~6bfa17cf50eb64a553379c2d6eeff50d